Latest News about FGEN
Recent news which mentions FGEN
From Benzinga
The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study
August 22, 2019
From Benzinga
31 Healthcare Stocks Moving In Today's Pre-Market Session
August 09, 2019
From Benzinga
52 Stocks Moving In Friday's Pre-Market Session
August 09, 2019
From Benzinga
From Benzinga
From Benzinga
72 Biggest Movers From Friday
May 13, 2019
From Benzinga
62 Stocks Moving In Friday's Mid-Day Session
May 10, 2019
From Benzinga
25 Stocks Moving In Friday's Pre-Market Session
May 10, 2019
From Benzinga
From Benzinga
The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stock To Debut
May 09, 2019
From Benzinga
Benzinga's Top Upgrades, Downgrades For April 12, 2019
April 12, 2019
From Benzinga
Biotech Stocks With Major Catalysts in April
April 02, 2019
From Motley Fool
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
March 23, 2019
From Benzinga
FibroGen Inc (FGEN) Q4 2018 Earnings Conference Call Transcript
February 27, 2019
Tickers
FGEN
From Motley Fool
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
December 30, 2018
From Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
December 20, 2018
From Benzinga
44 Stocks Moving In Wednesday's Mid-Day Session
December 19, 2018
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 19, 2018
December 19, 2018
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
December 18, 2018
From Benzinga
25 Stocks Moving In Tuesday's Pre-Market Session
December 18, 2018
From Benzinga
The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan
December 18, 2018
From Benzinga
The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut
October 31, 2018
From Benzinga
The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default
October 26, 2018
From Benzinga
The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price
October 25, 2018
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.